Status:
COMPLETED
Atrophic Gastritis and OLGIM Stage
Lead Sponsor:
Shandong University
Conditions:
Intestinal Metaplasia
Eligibility:
All Genders
40-75 years
Brief Summary
Three clinical research coordinators recruited patients aged 40-75 who underwent screening endoscopy at the Digestive Endoscopy Center of Qilu Hospital from July 1, 2022, to July 30, 2024. All partici...
Eligibility Criteria
Inclusion
- Inclusion criteria were patients aged 40-75 undergoing painless screening endoscopy
Exclusion
- 1\) previous gastric surgery; 2) inability to undergo biopsy due to anticoagulant use; 3) refusal to sign informed consent; 4) history of radiotherapy or chemotherapy; 5) new diagnosis of advanced gastric cancer during endoscopy; 6) failure to complete multiple-site biopsy for atrophic gastritis; and 7) diagnosis of non-atrophic gastritis during endoscopy.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 25 2024
Estimated Enrollment :
2121 Patients enrolled
Trial Details
Trial ID
NCT06585553
Start Date
July 1 2022
End Date
August 25 2024
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital
Jinan, Shandong, China, 250012